Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
06/2012
06/26/2012US8207311 Ovr115 antibody compositions and methods of use
06/26/2012US8207310 Antibodies to proteolysis inducing factor (PIF) receptor and methods of use thereof
06/26/2012US8207307 Antibodies against human CCN1 and uses thereof
06/26/2012US8207306 Targeted binding agents directed to sonic hedgehog homolog and uses thereof
06/26/2012US8207305 Sialoadhesin factor-2 antibodies
06/26/2012US8207304 Antibody antagonists of interleukin-13 receptor α1
06/26/2012US8207303 Monoclonal antibodies against CD30 lacking in fucosyl residues
06/26/2012US8207299 Citrulline peptides derived from fibrin and recognized by rheumatoid arthritis specific autoantibodies, and the use thereof
06/26/2012US8207131 Peptide
06/26/2012US8207123 Tumour-specific animal proteins
06/26/2012US8206977 Tricistronic vectors and uses therefor
06/26/2012US8206951 Stabilized liquid anti-RSV antibody formulations
06/26/2012US8206947 Human transmembrane proteins
06/26/2012US8206725 Immunogenic agent and pharmaceutical composition for use against homologous and heterologous pathogens including plasmodium SPP
06/26/2012US8206717 Antibodies against IL-25
06/26/2012US8206716 Methods of treating with anti-C5/C5a specific antibodies
06/26/2012US8206715 Antibodies that bind colony stimulating factor 1 receptor (CSF1R)
06/26/2012US8206714 Methods for treating rheumatoid arthritis using human antibodies that bind human TNFa
06/26/2012US8206713 Method of treating cancer using antibodies to a non-ligand binding region of NOTCH2
06/26/2012US8206711 Treatment of chronic lymphocytic leukemia using anti-CD20 antibodies
06/26/2012US8206709 Anti-NKG2A antibodies and uses thereof
06/26/2012US8206708 Vascular endothelial growth factor 2
06/26/2012US8206706 Method for enhancing or inhibiting insulin-like growth factor-I
06/26/2012CA2735129C Syngap1 dysfunctions and uses thereof in diagnostic and therapeutic applications for mental retardation
06/26/2012CA2526950C Method for determining immune system affecting compounds
06/26/2012CA2452716C Mammalian sweet and amino acid heterodimeric taste receptors
06/26/2012CA2405537C Vaccine comprising a tick cement protein
06/26/2012CA2263895C Therapeutic and diagnostic applications of perlecan domain i splice variants
06/21/2012WO2012083064A1 Silaanthracene as a red and near infrared sensor and a method to manufacture such a sensor
06/21/2012WO2012082073A1 Human monoclonal antibody with specificity for dengue virus serotype 1 e protein and uses thereof
06/21/2012WO2012081657A1 Preparation method for antigen-specific monoclonal antibody-producing hybridoma and production method for antigen-specific monoclonal antibody
06/21/2012WO2012080926A2 Anti-notch1 antibodies
06/21/2012WO2012080891A1 Anti-notch-1 antibodies
06/21/2012WO2012080769A1 Anti-cd277 antibodies and uses thereof
06/21/2012WO2012080642A1 Use of an antibody directed against a membrane protein
06/21/2012WO2012080518A1 Human anti-sod1 antibodies
06/21/2012WO2012080500A1 Serum amyloid p protein
06/21/2012WO2012080422A1 Method for separating, concentrating or purifying a (blood) plasma protein or viral component from a mixture
06/21/2012WO2012080389A1 Combination therapy of an afucosylated cd20 antibody with a mdm2 inhibitor
06/21/2012WO2012080351A1 Anti-cd277 antibodies and uses thereof
06/21/2012WO2012080306A1 Cd89 activation in therapy
06/21/2012WO2012079488A1 P28gank monoclonal antibody and peptides for preparation thereof and use thereof
06/21/2012WO2012079370A1 Verticillium dahliae protein elicitor gene, protein sequence and use thereof
06/21/2012WO2012058665A9 Compositions and methods for modulation and detection of immune and inflammatory responses
06/21/2012WO2012058308A3 Antibody based reagent that specifically recognizes toxic oligomeric form of beta-amyloid
06/21/2012WO2012058220A3 Anti-sod1 antibodies and uses thereof
06/21/2012WO2012047294A3 Antibodies directed against hla-b27 homodimers and methods and uses thereof in diagnosis and therapy
06/21/2012WO2012045481A8 Antibody targeting osteoclast-related protein siglec-15
06/21/2012WO2012038504A3 Breast cancer therapeutics
06/21/2012WO2012022982A3 Improved antibodies of the class igg4
06/21/2012WO2012021512A3 Erythrocyte-binding therapeutics
06/21/2012US20120159672 Sequence-determined DNA fragments and corresponding polypeptides encoded thereby
06/21/2012US20120159660 Desaturases and methods of using them for synthesis of polyunsaturated fatty acids
06/21/2012US20120159655 Methods using axl as a biomarker of epithelial-to-mesenchymal transition
06/21/2012US20120157667 Methods Of Producing Humanized Non-Human Mammals
06/21/2012US20120157666 Interferon-like proteins and uses thereof
06/21/2012US20120157665 Gram-positive bacteria specific binding compounds
06/21/2012US20120157664 Method for the production of domain antibodies
06/21/2012US20120157663 Antibody identifying an antigen-bound antibody and an antigen-unbound antibody, and method for preparing the same
06/21/2012US20120157662 Means and methods for producing high affinity antibodies
06/21/2012US20120157379 Gastric Inhibitory Peptide Variants and Their Uses
06/21/2012US20120157372 Human milk peptides
06/21/2012US20120157338 Method for determining the risk of developing brain metastasis, and a kit to carry out said method
06/21/2012US20120157335 Flap Endonuclease-1 As A Marker For Cancer
06/21/2012US20120156771 Functional disruption of an immunoglobulin gene in an avian embryonic stem cell
06/21/2012US20120156770 Human androgen receptor alternative splice variants
06/21/2012US20120156725 Human Anti-OPGL Neutralizing Antibodies As Selective OPGL Pathway Inhibitors
06/21/2012US20120156724 Humanized anti-cd47 antibody
06/21/2012US20120156704 In vitro method for detecting gp91phox as a marker of oxidative stress
06/21/2012US20120156700 Detection and quantitation of urine gelsolin
06/21/2012US20120156699 Pathogenic TH17 Cells; related reagents and methods
06/21/2012US20120156681 Composition for diagnosis of liver metastasis of colorectal cancer and the use thereof
06/21/2012US20120156242 An Antigenic Peptide Derived From Influenza Virus And A Method For Selecting Anti-Influenza Virus Antibody
06/21/2012US20120156236 Neisseria meningitidis antigens and compositions
06/21/2012US20120156235 Antibodies Against And Methods For Producing Vaccines For Respiratory Syncytial Virus
06/21/2012US20120156227 Proteins modified with (amino) monosaccharide-biotin adduct
06/21/2012US20120156226 Marker Differentially Expressed in Cancer Stem Cells and Methods of Using Same
06/21/2012US20120156222 Prevention and treatment of alzheimer's disease
06/21/2012US20120156220 Methods and compositions for inhibiting cd32b expressing cells
06/21/2012US20120156218 Novel anti-cd38 antibodies for the treatment of cancer
06/21/2012US20120156217 Novel EGFR-Binding Molecules and Immunoconjugates Thereof
06/21/2012US20120156216 Methods and Compositions for Treatment of Tumor Metastasis
06/21/2012US20120156214 Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological diseases
06/21/2012US20120156213 Method for treating th17 inflammatory disease through inhibition of vascular endothelial growth factor receptors and pharmaceutical composition therefor
06/21/2012US20120156211 Porphyromonas gingivalis polypeptides
06/21/2012US20120156210 Methods of treatment using anti-il-22ra antibodies
06/21/2012US20120156209 Anti-il-tif antibodies and methods of use
06/21/2012US20120156206 C-met antibody combinations
06/21/2012US20120156203 Novel anti-il13 antibodies and uses thereof
06/21/2012US20120156201 Humanized antibodies specific for hsp65-derived peptide-6 methods and uses thereof
06/21/2012US20120156198 Antibodies against IL-18R1 and uses thereof
06/21/2012US20120156195 Human-Murine Chimeric Antibodies Against Respiratory Syncytial Virus
06/21/2012US20120156194 Diagnosis and treatments relating to th2 inhibition
06/21/2012US20120156193 Antibodies That Specifically Bind to A Beta Oligomers and Use Thereof
06/21/2012US20120156134 Compositions and methods for detecting or eliminating senescent cells to diagnose or treat disease
06/21/2012US20120155620 Personal-Call and Feature Control System and Method for Controlling Telephones, Providing Extended Features for Such Telephones and Routing of Media-Rich Calls
06/21/2012CA2821296A1 Cd89 activation in therapy
06/21/2012CA2821268A1 Human monoclonal antibody with specificity for dengue virus serotype 1 e protein and uses thereof
06/21/2012CA2821130A1 Anti-notch1 antibodies
06/21/2012CA2821022A1 A monoclonal antibody against p28gank, the polypeptide used to prepare this antibody and their applications
1 ... 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 ... 1494